AbbVie (ABBV) - 4 Year Stock Price History
Historical daily stock prices for AbbVie since 2013 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for AbbVie (ABBV) as of August 16, 2017 is 70.42.
|Medical||Large Cap Pharmaceutical||$112.129B||$25.638B|
|AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.|